To enhance the liver-specific functions of rat hepatocyte aggregates without the addition of exogenous growth factors, polylactic acid-polyglycolic acid (PLGA)/gelatin microcapsules that release insulin, dexamethasone, epidermal growth factors, and glucagon were prepared and incorporated into the hepatocyte aggregates in suspension culture. Precoating the capsules with fibronectin enhanced the incorporation of the microcapsules into the hepatocyte aggregates. In a growth factor-and hormone-free culture medium, these microcapsule-containing aggregates showed a sustained cell number and an ammonium detoxification capacity compared with two types of control culture. One was the culture of microcapsule-free aggregates with albumin-containing control capsules and the other was the culture of capsule-free aggregates that were supplied with the same factors and hormones from the culture medium at concentration levels expected from the release kinetics of the microcapsules. Our new methodology demonstrates that the performance and duration of bioartificial liver systems can be enhanced due to a more efficient maintenance of cell number by using such growth factor-and hormone-releasing microcapsules.
INTRODUCTION
In order to partly attenuate this situation, and to improve the performance of in vitro reconstituted liver tis-As an effective treatment of patients with various sue, some approaches using basic techniques of tissue types of liver failure, a bioartificial liver system using engineering have been tried. These include local delivxenogeneic hepatocytes is very promising (9). However, ery of epidermal growth factor (EGF) to implanted hefurther improvement in system performance is needed, patocytes using biodegradable polymer microcapsules because the life-saving effect of current systems is low (7) or pretransfection of hepatocyte aggregates with the in the treatment of patients with severe liver failure, ingene of vascular endothelial growth factor (VEGF) (1). cluding subacute or acute-on-chronic types (9).
In animal experiments, both of these studies succeeded Aggregate culture of rat or porcine hepatocytes has in enhancing hepatocyte survival or vascularization from been demonstrated to be superior to other conventional the surrounding host tissue after the implantation. These culture techniques. Therefore, various research groups, basic techniques in tissue engineering research are also including ours, have attempted the use of this technique likely to be beneficial when we think about further enin bioartificial liver systems (4,8,10). However, longhancement of the performance of bioartificial liver systerm maintenance of the viability and function of hepatems. tocytes in the actual operation of bioartificial liver sys-As a trial to enhance the performance of bioartificial tems is still difficult, because the cells are attacked by systems using hepatocyte aggregates, we organized biothe host's immune system and they are only supplied hybrid liver tissue consisting of rat hepatocytes and biowith a physiological concentration of growth factors or degradable polymer-based microcapsules that release hormones. This situation is completely different from four kinds of growth factors and hormones. The biohythat of the ideal in vitro cell culture, where these factors brid liver tissue was formed in small-scale suspension can be supplemented at concentration levels that exceed culture by enhancing the adhesiveness between the hephysiologically reasonable ranges. patocytes and microcapsules. Changes in cell number tube and the same volume of fresh culture medium was added to the original tube that contained the precipitated and function of this tissue were investigated in a serumcontaining culture medium that did not contain exoge-microcapsules. Four milliliters of 5% sodium dodecylsulfate (SDS) in 0.2 N of NaOH was added to both se-nous growth factors or hormones.
ries of samples, and they were vigorously shaken at MATERIALS AND METHODS 37°C for 2 h (3) to break up the microcapsules. Fluores-Preparation of Growth Factor-and Hormonecence at an excitation wavelength of 490 nm and at an Releasing Microcapsules emission wavelength of 525 nm was measured and the amount of FITC-BSA released and that was still entrap-Polylactic-polyglycolic acid (PLGA; lactic acid/glyped in the capsules was determined. col acid = 75:25, mol.wt. = 20,000; Wako)/gelatin (Wako) microcapsules were prepared according to a conven-Formation and Culture of Biohybrid Liver Tissue tional double-emulsion technique (5). Briefly, 50 µl of Rat hepatocytes were isolated, purified, mixed with a growth factor-and hormone-containing aqueous soluone fifth their number of microcapsules, and cultured in tion was dispersed in 1 ml of 5% PLGA in dichloroa 60-mm siliconized glass dish on a rotatory shaker at a methane by sonification (50 W, 30 s) in an ice bath. Ten rotational speed of 70 rpm. The culture medium during milliliters of 2% gelatin in phosphate-buffered saline the first 40 h was William's medium E supplemented (PBS) was gently overlaid above the emulsified solution with 20% heat-inactivated fetal bovine serum, 0.5 mM and vortexed, vigorously, for 60 s. The mixture was then ascorbic acid diphosphate (Wako), and 10 −6 M insulin, poured into 100 ml of 2% gelatin in PBS that was stirred 10 −5 M dexamethasone, 20 ng rhEGF/ml, and antibiotics at 1000 rpm. After 5 min of stirring, the rotational speed (8). The inoculated cell density was 2.0 × 10 6 cells/ml. was lowered to 500 rpm and the stirring was continued After 40 h of culture with two medium exchanges, at 8 up to 3 h at room temperature. The formed microcapand 24 h, the aggregates were collected and washed sules were filtered with a stainless mesh of 58-µm pore twice with culture medium, and reinoculated in the same size and washed extensively with distilled water. They glass dishes in new culture medium supplemented only were gently incubated with 20 µg bovine fibronectin with 20% heat-inactivated bovine serum and antibiotics. (Takara, Osaka, Japan)/ml water at 37°C for 2 h, then
The culture medium was replenished thereafter at 2-day washed with distilled water, freeze-dried, sterilized with intervals. ethylene oxide gas, and stored at −20°C until use.
We immobilized four kinds of growth factors and Measurements of Cell Number, Damage, and Functions hormones [i.e., insulin (Takara); dexamethasone (water-Cell number in terms of the DNA content was measoluble product formed by coupling dexamethasone with sured at various periods by 4′,6-diaminodino-2-phenylin-2-hydroxypropyl-β-cychlodexitrin, Sigma-Aldrich, St. dol (DAPI) fluorometry (2). Isolated 10 6 rat hepato-Louis, MO); glucagon (Sigma-Aldrich); and recombicytes corresponded to 22.1 ± 3.4 µg of calf thymus nant human epidermal growth factor (rhEGF; Austral DNA (N = 3). A diagnostic kit (GOT-UV Test; Wako) Biologicals, CA)] in microcapsules. One preparation of measured the GOT activity leaking from the cultured microcapsules (50 µl of solution containing these faccells. The culture medium was supplemented with 1 mM tors) contained 5.0 mg (1 × 10 −6 mol) of insulin, 0.32 mg of ammonium chloride and its removal rate by the hepaof dexamethasone (1 × 10 −6 mol), 0.50 mg (1 × 10 −7 mol) tocyte aggregates was measured by the indophenol of glucagon, and 50 µg (1 × 10 −8 mol) of rhEGF. Control method (6). capsules immobilized 10 mg of bovine serum albumin (BSA; Sigma-Aldrich) instead of the growth factors and RESULTS AND DISCUSSION hormones.
Release Characteristics of Prepared Microcapsules Clarification of Fundamental Characteristics
Using the model microcapsules containing FITCof Microcapsules BSA, 58.1 ± 1.5% (mean ± SD, N = 3) of the FITC-BSA amount fed at the start of the capsule preparation was Model capsules that immobilized fluoresceine isothianate (FITC)-labeled BSA (1.0 mg in addition to nonla-observed in the capsule fraction with a diameter below 58 µm. This was further lowered to 39.4 ± 3.3% (N = 3) beled BSA, Sigma-Aldrich) were prepared in the same manner as described above. An appropriate amount of during lyophilization, sterilization, and resuspension in culture medium. Figure 1 shows a scanning electron mi-the prepared microcapsules was placed in a 50-ml tube with the same culture medium as described below, and crograph of the lyophilized microcapsules in one such preparation, which were subsequently used in the release gently shaken at 37°C. At each time interval, 1 ml of the suspension was sampled and centrifuged at 2000 rpm for study. The mean diameter and SD of the microcapsules was 12.3 ± 7.9 µm (count of 100-200 capsules). Release 5 min. The supernatant was transferred to another test
Formation of Biohybrid Liver Tissue
When rat hepatocytes were cocultivated with one fifth their concentration of microcapsules, almost all of the fibronectin-coated microcapsules adhered to the rat hepatocytes in the first 8 h. Preliminary experiments showed that the fibronectin-free capsules remained suspended without connecting with the hepatocytes or with forming hepatocyte-free capsule aggregates even after 24 h (data not shown). At 24 h, small aggregates containing microcapsules were successfully formed. The surface of the aggregates became smooth at 40 h (Fig.  3) . The mean diameter and SD of the aggregates was 180 ± 56 µm for the capsule-free culture and 153 ± 78 µm for the capsule-containing culture at 40 h. During the 40 h of rotational culture for aggregate formation, the time course of GOT leakage was similar irrespective 4A). We therefore concluded that cocultivation with fibronectin-coated microcapsules does not cause serious damage to rat hepatocytes. Cocultivation with microcapof the encapsulated FITC-BSA was rapid within the first sules tended to slightly lower the organization of the day due to capsules of the very small diameter or to cells into aggregates (Fig. 4B ). This seems to show that FITC-BSA that was adsorbed onto the capsule surfaces cell-to-cell interaction is slightly stronger than that of ( Fig. 2) (7) . During further incubations, however, the cell-to-fibronectin-coated microcapsules. Enhancing inrelease rate became lower and constant. This may repreteraction between microcapsules and hepatocytes could sent the degradation of PLGA by hydrolysis (Fig. 2) .
attain further enhancement of the organization ratio. The observed release rate is in a reasonable range, as Cell Number and Ammonium Removal Capacity observed in EGF release from PLGA-polyethyleneglycol microcapsules (7).
Four types of culture were carried out to clarify the effects of the incorporated microcapsules that release growth factors and hormones on hepatocyte performance (Fig. 5 ). In addition to the usual aggregate culture (w/o capsules) and culture of aggregates containing control capsules (w/BSA capsules), another control culture of capsule-free aggregates that was supplied with the same four growth factors and hormones from the culture medium (w/o capsules, w/IDEG) was carried out. On the Therefore, the four growth factors and hormones were supplemented at these concentration levels in the control basis of the release study using FITC-BSA-containing capsules (Fig. 2) , about 2% amount of encapsulated culture (w/o capsules, w/IDEG). Cell number maintenance of the growth factor-and factors was presumed to be released every 2 days. This was roughly equivalent to the 2-day interval-based sup-hormone-containing aggregates (w/IDEG capsules) was significantly enhanced compared with the other three ply of culture medium containing 10 −9 M insulin, 10 −9 M dexamethasone, 10 −11 M rhEGF, and 10 −10 M glucagon.
cultures, particularly after week 1. Control capsules im- Figure 5 . Changes in cell number in terms of DNA amount (A) and in ammonium removal capacity (B) during 2 weeks of culture. Each point represents the mean ± SD from three dishes.
